ºÚÁÏÍø

The effects of increased therapy time on cognition and mood in frail patients with a stroke who rehabilitate on rehabilitation units of nursing homes in the Netherlands: A protocol of a comparative study

J Alzheimers Dis Parkinsonism

DOI:

Marleen Huijben-Schoenmakers

HTML PDF Digital File

Hyperkinetic movement disorders, differential diagnosis and treatment

J Alzheimers Dis Parkinsonism

DOI:

Arunasalam Balamanogaran

HTML PDF Digital File

Curcumin’s neuroprotective efficacy in Drosophila model of idiopathic Parkinson’s disease is phase specific: Implication of its therapeutic effectiveness

J Alzheimers Dis Parkinsonism

DOI:

Limamanen Phom

HTML PDF Digital File

Protective effects of rosmarinic acid against iron-induced neurotoxicity in SK-N-SH cells

J Alzheimers Dis Parkinsonism

DOI:

Huamin Xu

HTML PDF Digital File

Mice expressing the A53T mutant form of human alpha-synuclein exhibit unexpected improvements of spatial learning and memory abilities

J Alzheimers Dis Parkinsonism

DOI:

Ze Gang Ma

HTML PDF Digital File

Bi-directional modulation by HCN channels on globus pallidus neurons

J Alzheimers Dis Parkinsonism

DOI:

Lei Chen

HTML PDF Digital File

GPER agonist G1 attenuates LPS-induced inflammatory responses in murine BV-2 microglial cells

J Alzheimers Dis Parkinsonism

DOI:

Wen-Fang Chen

HTML PDF Digital File

Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the Keap1- Nrf2-ARE pathway and inhibiting the MAPKs and NF-κB pathways

J Alzheimers Dis Parkinsonism

DOI:

Ik-Hyun Cho

HTML PDF Digital File

Protective effects and mechanisms of rosmarinic acid against rotenone induced Parkinson’s disease models

J Alzheimers Dis Parkinsonism

DOI:

Jun-Xia Xie

HTML PDF Digital File

NR2B antagonist ifenprodil improves abnormal forelimb movement induced by D1R agonist SKF38393 in hemiperkinsonian rats

J Alzheimers Dis Parkinsonism

DOI:

Toshiya Habata

HTML PDF Digital File

Treatment of dystonia and tremors in Parkinson’s disease

J Alzheimers Dis Parkinsonism

DOI:

Sanjay Jaiswal

HTML PDF Digital File

Characterizing the mode of action of beta-2 adrenergic receptor agonists: A therapeutic agent for Parkinson’s disease

J Alzheimers Dis Parkinsonism

DOI:

Naik Bakht Arbabzada

HTML PDF Digital File

Hippocampal neuroprotective effects of coenzyme Q10 against 1-methyl-4-phenyl-1,2,3,4- tetrahydropyridine-induced Parkinson’s disease model in albino rats

J Alzheimers Dis Parkinsonism

DOI:

Sahar Mohamed Kamal Shams El-Dine

HTML PDF Digital File

The changes of CD4+CD25+FoxP3 and which related inflammatory factors in the peripheral blood of patients with early Parkinson’s

J Alzheimers Dis Parkinsonism

DOI:

Yue Erli

HTML PDF Digital File

Identifying REM-sleep behavior disorder by the RBD screening questionnaire in non-neurological patients

J Alzheimers Dis Parkinsonism

DOI:

Markus Schymalla

HTML PDF Digital File

Neuropathology and pathogenesis of multiple system atrophy: An update

J Alzheimers Dis Parkinsonism

DOI:

Kurt A Jellinger

HTML PDF Digital File

Parkinson’s disease and movement disorder: Development of a novel human cell model as a model for Parkinson’s disease

J Alzheimers Dis Parkinsonism

DOI:

Bushra Ahmed

HTML PDF Digital File

Update on treatment and care in Huntington’s disease: European Huntington’s disease network perspective

J Alzheimers Dis Parkinsonism

DOI:

Daniel Zielonka

HTML PDF Digital File

Basal ganglia oscillations in Parkinson´s disease: From rodents to humans

J Alzheimers Dis Parkinsonism

DOI:

Ledia F Hernandez

HTML PDF Digital File

Navigating life with Parkinson’s: A perspective from a medical educator

J Alzheimers Dis Parkinsonism

DOI:

Frank C Church

HTML PDF Digital File

The interplay between synuclein alpha, sphingolipids signaling and sirtuins in molecular mechanism of dopaminergic cells death in Parkinson Disease experimental model

J Alzheimers Dis Parkinsonism

DOI:

Joanna B Strosznajder

HTML PDF Digital File